GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DuoGenic StemCells Corp (ROCO:7607) » Definitions » Treasury Stock

DuoGenic StemCells (ROCO:7607) Treasury Stock : NT$0.00 Mil (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is DuoGenic StemCells Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. DuoGenic StemCells's treasury stock for the quarter that ended in Jun. 2024 was NT$0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.


DuoGenic StemCells Treasury Stock Historical Data

The historical data trend for DuoGenic StemCells's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DuoGenic StemCells Treasury Stock Chart

DuoGenic StemCells Annual Data
Trend Dec21 Dec22 Dec23
Treasury Stock
- - -

DuoGenic StemCells Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Treasury Stock Get a 7-Day Free Trial - - - - -

DuoGenic StemCells Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.


DuoGenic StemCells Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Room R207, Innovation Incubation Center, 145, Xingda Road, South District, Taichung, TWN
DuoGenic StemCells Corp is a company having a team of passionate researchers focused on stem cell cultivation. Their products are intended for research use and can be upgraded for clinical applications. It also develops blood cell therapy programs, using the isolation and purification of blood mononuclear cells to remove granule cells that promote inflammation, and conducts clinical trials on various degenerative diseases to provide a convenient and simple new option for cell therapy.

DuoGenic StemCells Headlines

No Headlines